|
Day 1 :: Day 2
| Day
1 – June 1st, 2006 |
Chairperson’s Opening Address: Mike Rea, CEO, IdeaPharma |
Opening
Keynote Presentation: How patient compliance
is increasingly becoming an integral part of the pharma
business across Europe
Learn why building trust can enhance your brand. Hear why compliance drives long term loyalty for your brand and products and why you can’t afford to ignore the issue in your strategic planning.
Patricia Stenger, Director, Scientific Affairs,
Bayer Healthcare |
Presentation:
From development to implementation
of an effective compliance programme:
Lessons learned
- Find out how patient compliance can bring win-win
benefits for your product development and branding
and for your patients
- From programme concept to programme development
– what you need to know to successfully initiate
an effective patient compliance strategy
- Hear about the challenge of internal and external
barriers to investing in patient compliance …
and how you can overcome them in your company
- It’s all about the response! Get smarter
in your project implementation by establishing a
good feedback loop
Brigitte
Schau, Manager Value Added Services,
Boehringer Ingelheim GmbH
|
|
Presentation:
A new business model for the pharma industry
– Learn how to increase your revenues and profitability
from improved persistence and compliance
- Discover why you need to take the lead in developing
successful approaches to improving persistence and
face up to market pressure and the growing expectations
of payers
- Learn how to make the best use of medication monitoring
to enhance persistence across multiple therapy areas
- Find out why reducing communication and technology
costs is the only “scaleable” approach
to deliver better persistence for large population
groups
- Discover new, clinically proven HIPAA compliant
turn-key patient management solutions offered on
a risk/reward basis that will ensure benefits to
patients, providers, payers and help you to uncover
the hidden blockbuster in your portfolio
Bernard
Vrijens, Chief Scientist, Pharmionic
Systems Ltd.
|
| Networking Break and Exhibition |
WHAT’S WORKING
AND WHY? INNOVATIVE NEW IDEAS IN PATIENT COMPLIANCE
DEVELOPMENT AND IMPLEMENTATION |
Presentation: The Future belongs to Branded Compliance Management
- Understand the significance of patient compliance
in good brand strategy
- Learn how you can use branded compliance management
to successfully differentiate your company and products
from your competition
- Hear case study examples of branded value added
services in action in the realm of patient marketing
- Discover how you can share costs to alleviate
your risk and maximise your reward in the implementation
of your programmes
Dr. Roman Rittweger,
Managing Partner, BBDO Consulting
GmbH |
Panel Debate:
Patient Compliance: Who’s Responsible
and Who Pays?
- Hear why doctors and primary care providers are
seen as the sole guardians of responsibility for
patient adherence across Europe – is this
a fair representation of the situation?
- Where does the direct responsibility of pharma
companies lie? Is there scope for a more hand-on
role or will they realistically continue to be seen
principally as fund providers?
- Get first hand opinion on the role of payer organisations
and health insurers in improving patient adherence
- What about the role of patients themselves, and
the role of the associations that represent them?
The latest news on initiatives being developed across
Europe
Patricia Stenger,
Director, Scientific Affairs, Bayer
Healthcare
Alex Wyke , Chief Executive,
PatientView
Helmut Hildebrandt, Chairman, Hildebrandt
GesundheitsConsult GmbH
|
| Networking Lunch & Exhibition |
THE IMPACT OF REGULATION ON YOUR PATIENT COMPLIANCE PROGRAMME DELIVERY |
Presentation:
Understanding Regulation across Europe. What
can pharma companies actually do in terms of patient
communication?
- Understand the real state-of-play in patient communication
regulation across the continent and how this can
affect your compliance programme planning and implementation
- Discover exactly what you can and what
you can’t do in communication with patients
in different European markets
- Learn the real differences between information
on disease areas, products and the company and how
this can affect your communication strategies
- Get the inside track on what the major issues
are in the protection of patient data. Hear how
can you get the statistics and figures you need
to make your patient compliance programmes work
better
Alex
Wyke , Chief Executive, PatientView
|
HOW TO DELIVER BETTER PATIENT COMMUNICATIONS |
Case
study: How to integrate mobile and web based
programmes to drive better patient adherence to your
products
- Find out why mobile phone technology is the next
big mechanism to drive patient adherence easily
and affordably
- Discover how patient-doctor communication is improved
through SMS and how this brings better possibilities
for patient adherence to your product portfolio
- Good for the patient, good for the doctor, good
for your products! Hear how an integrated
system enables doctors to log on the web and see
if patients are compliant … and the benefits
this data will bring to your measurement
Stephan Kerkojus,
Group Product Manager, Stallergenes
Tanja Antwerpes, Board Member,
Antwerpes & Partner |
Presentation: The use of Interactive Voice Response and Interactive Web Response in disease management and compliance programmes
- Get detailed information on the use and benefits
of IVR in collection of patient reported outcomes
in clinical trials
- Understand the value of using simple computerised
assessment instruments in providing valuable feedback
to patient, sponsor and physician
- New models for use of IVR/IWR in disease management
and compliance programmes
- Hear brand new case studies in patient adherence
and education using IVR
Bill Byrom, Product Strategy Director, ClinPhone |
| Networking Break and Exhibition |
Extended Panel Debate: “Right Channelling” – How to decide which marketing channels work best for which patients
- Know your patient! Hear why you can no longer
segment patient outreach according to assumptions
on behaviour patterns of patient groups
- Top tips on how to develop a wrap around strategy
for your marketing. Discover how effective channel
integration can mean the difference between success
and failure for your patient compliance programmes
- Drill down into the costs and tangible benefits
of specific channels you’re using to get your
message out to your patients
- Find out which approaches work for which
patients – and how you can apply this knowledge
to improve your own marketing strategy
Len Starnes, Head
European E-Business, Schering AG
Di Stafford, Director, The
Patient Practice (Former Head of Patient
Relationship Marketing, Pfizer UK )
Yvonne van der Schouw , Patient
Relations Manager, Abbott
Michel Dubery, Partner,
Rapp Collins Consumer Health
Dr. Antje-Henriette Fink-Wagner,
Manager Professional Relations, Global Franchise
Respiratory, Altana Pharma AG
Moderated
by: Jay Bolling, Managing Partner,
Roska Direct |
| End of Day 1 - Back To Top |
| Day
2 – June 2nd, 2006 - Back To
Top |
|
PACKAGING
& COMPLIANCE
-----------------------------------------------------
Presentation:
Why improving your packaging is the key to
improving your patient adherence
• Get the
latest on the real impact of packaging on patient
compliance and adherence
• How can you
best ensure that the information and advice you're
providing your patients actually gets read?
• What can
and can't you do with product
packaging –
what are the limits for big pharma?
Tassilo Korab, Executive Director,
HCPC (Healthcare Compliance Packaging Council) |
PATIENT
COMPLIANCE ROUNDTABLES
-----------------------------------------------------
6 advanced
roundtables on key aspects of patient compliance and
patient centred marketing (led by industry experts).
-------------------------------------------
1)
How to benchmark patient compliance and set realistic
targets for your programmes
What are
you looking to do with your patient programmes? Make
sure the goals you set are workable and that you'll
get maximum benefit from them.
Led by:
Len Starnes, Head European
E-Business,
Schering AG
-------------------------------------------
2)
How to measure patient compliance and calculate
real ROI
You need
to be measuring the success of your programmes and
analysing the real costs and benefits. Find out here
how to recognise the true impact on your bottom line
and how you can deliver positive figures to the board.
Led by:
Jay Bolling, Managing Partner, Roska
Direct
-------------------------------------------
3)
Patient education and links to patient compliance.
How to ensure you get your information right
Learn how
you can better provide information to patients without
constant recourse to external consultants. Hear how
leaflets can play a major part in delivering the right
advice to patients to give you the best chance of
them staying compliant.
Led by:
David Bertholon, Patient Relations
Manager, Schering Plough
-------------------------------------------
4)
The future of patient compliance in Europe – where
do we go from here?
What's next
for patient compliance? It's already rapidly rising
up the corporate agenda and becoming a key strategic
issue, so where will it be in five years time?
Led by: Di
Stafford, Director, The
Patient Practice (Former Head of Patient
Relationship Marketing, Pfizer UK )
-------------------------------------------
|
Presentation:
Where the main benefits of compliance packaging
lie for big pharma
• Hear why
packaging should be a key feature in good patient
compliance programme development
• Why clarity
is the key – how to make sure you get the right message
across to your patients in the right way
• Find out
how a major pharmaceutical company has taken packaging
on board as a significant new DTP marketing channel
• What ROI
can you expect to see? Is the
investment
really worth it?
Check
www.eyeforpharma.com/pceuro06 for
speaker updates for this session |
|
Panel Debate:
Thinking inside the box!
The best ways to ensure you get your packaging right
This session
is dedicated to high level discussion of the key issues
in packaging design, manufacture and distribution.
Ask the questions you want answered and guarantee
that you get the best value from your packaging spend
by helping to increase your patient compliance rates.
Thomas
R. Grinnan , Director, Healthcare Packaging
Europe , MeadWestvaco Corporation
Tassilo Korab, Executive Director,
HCPC (Healthcare Compliance Packaging Council)
Bernard Bousquet,
Development Director, ABR Pharma
|
| Coffee
and Networking |
|
Presentation:
Compliance? Adherence? What does the patient
want?
An insight
into research done directly with patients. Can using
the wrong teminology turn patients off and put your
programmes in jeopardy?
Nick
Hicks, Consultant, European
MS Platform |
HOW
TO GET BUY-IN FOR INVESTMENT FROM ACROSS YOUR BUSINESS |
Panel
Debate: Which disciplines in your business
need to come together to guarantee effective delivery
of compliance programmes?
- How to promote a multi-disciplinary approach to
improving patient adherence across your business
– and how securing this will make your patient
compliance programme planning far easier
- Identifying the areas of your business that should
be involved and developing a concrete list of responsibilities
to ensure efficiency and success
- Guidelines on adopting and integrating patient
compliance projects across your business
- Get a direct forecast from the industry on where
responsibility for driving patient compliance programmes
is going in the next five years
David Bertholon, Patient Relations
Manager, Schering Plough
Di Stafford, Director, The
Patient Practice (Former Head of Patient
Relationship Marketing, Pfizer UK )
Søren E. Skovlund, Senior Adviser,
Stakeholder Relations, Novo Nordisk |
Presentation:
How to measure ROI and deliver a business
case for patient compliance
The “holy grail” of patient compliance
is delivering good ROI for your business. This presentation
will give you the tools you need to demonstrate an
effective business case for investment in patient
focused programmes.
- Hear how and why investment in patient adherence
programmes can bring far reaching gains for your
company
- Learn how to convince cynical colleagues of the
value that patient marketing can bring to your business
- Discover how payer organisations are beginning
to sit up and take notice and how you can get the
statistics to promote a real business case
Mark Nuijten,
Health Care Management, Erasmus
University |
| Networking
Lunch & Exhibition |
THE
IMPORTANCE OF COLLABORATION |
Extended
Panel Debate: Joined up thinking. How collaboration
with key stakeholder groups can open up new areas
of opportunity in patient compliance
- Learn who you need to be working with to ensure
your patient programmes stay on track
- Assess the role of pharmacists, patient associations
and payer organisations in delivering improved persistence
results
- Doctors and key opinion leaders (KOLs) –
what’s their role and how can you work best
with them?
- How you can work directly with patients themselves
to make sure you’re hitting the right buttons
with your marketing and wider patient communications
Adrienne van Strein,
Manager Pharmaceutical Healthcare, GSK
Rebecca Bloor, Healthcare Development
Manager, Wyeth Pharmaceuticals
Helmut Hildebrandt,
Chairman, Hildebrandt
GesundheitsConsult GmbH |
Final
Session: Future Perspectives: A recap of key
learnings from the conference and perspectives on
what the future holds for patient compliance in Europe
Chaired by: Mike Rea,
CEO, IdeaPharma |
| End
of Conference - Back To Top |
|
 |
|
